John M. Desmarais serves as Executive at BioRestorative Therapies, Inc., where they oversee executive responsibilities. Since joining the company, John M. Desmarais has executed 5 insider transactions totaling $1.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 1, 2017 involved receiving (via award) 16,667 shares valued at $50.0K.
John M. Desmarais currently holds 493,398 shares of BioRestorative Therapies, Inc. (BRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John M. Desmarais has been a net buyer of BRTX stock. They have purchased $1.5M and sold $0 worth of shares.
John M. Desmarais's most recent insider trade was on Mar 1, 2017, when they sold 16,667 shares at $3.00 per share.
Get notified when new Form 4 filings are submitted
| $3.00 |
| Discretionary |
| Sep 26, 2016 | BRTX | $240.0K | Purchase | 80,000 | $3.00 | Discretionary |
| Sep 26, 2016 | BRTX | $240.0K | Purchase | 80,000 | $3.00 | Discretionary |
| Mar 18, 2016 | BRTX | $1.0M | Purchase | 250,000 | $4.00 | Discretionary |